Moloney Securities Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
EAM
Moloney Securities Asset Management's NEO Position: Q2 2020 in Review
Moloney Securities Asset Management sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 12,444 shares — an estimated $344K sold.
Moloney Securities Asset Management first reported a position in NEO in Q3 2019 and held it in 3 quarters. The position peaked at $371K in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.
- Moloney Securities Asset Management reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
- Moloney Securities Asset Management sold 12,444 NeoGenomics shares in Q2 2020, an estimated $344K.
- Moloney Securities Asset Management first reported a position in NeoGenomics in Q3 2019 and held it in 3 quarters.
- Moloney Securities Asset Management's NeoGenomics position peaked at $371K in Q4 2019.
- 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.
Based on Moloney Securities Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.